Works matching Flaviviral diseases


Results: 946
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    West Nile virus infection and immunity.

    Published in:
    Nature Reviews Microbiology, 2013, v. 11, n. 2, p. 115, doi. 10.1038/nrmicro2950
    By:
    • Suthar, Mehul S.;
    • Diamond, Michael S.;
    • Gale Jr, Michael
    Publication type:
    Article
    12
    13
    14
    15
    16

    Results of salvage liver transplantation.

    Published in:
    Liver International, 2014, v. 34, n. 6, p. e96, doi. 10.1111/liv.12497
    By:
    • Guerrini, Gian Piero;
    • Gerunda, Giorgio E.;
    • Montalti, Roberto;
    • Ballarin, Roberto;
    • Cautero, Nicola;
    • De Ruvo, Nicola;
    • Spaggiari, Mario;
    • Di Benedetto, Fabrizio
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    On the web.

    Published in:
    2010
    Publication type:
    Web Site Review
    25
    26
    27

    Journal scan.

    Published in:
    Emergency Nurse, 2016, v. 24, n. 2, p. 17
    Publication type:
    Article
    28

    Noticeboard.

    Published in:
    Emergency Nurse, 2016, v. 24, n. 2, p. 16, doi. 10.7748/en.24.2.16.s19
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    ISG15/USP18/STAT2 is a molecular hub regulating IFN Imediated control of Dengue and Zika virus replication.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1331731
    By:
    • Eleonora Espada, Constanza;
    • Lummertz da Rocha, Edroaldo;
    • Ricciardi-Jorge, Taissa;
    • Aurea dos Santos, Adara;
    • Guerra Soares, Zamira;
    • Malaquias, Greicy;
    • Oliveira Patrício, Daniel;
    • Gonzalez Kozlova, Edgar;
    • Fernandes dos Santos, Paula;
    • Bordignon, Juliano;
    • Sanford, Thomas J.;
    • Fajardo, Teodoro;
    • Sweeney, Trevor R.;
    • Báfica, André;
    • Santos Mansur, Daniel
    Publication type:
    Article
    36
    37
    38

    Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

    Published in:
    Journal of Viral Hepatitis, 2010, v. 17, n. 5, p. 336, doi. 10.1111/j.1365-2893.2009.01182.x
    By:
    • Inoue, Y.;
    • Hiramatsu, N.;
    • Oze, T.;
    • Yakushijin, T.;
    • Mochizuki, K.;
    • Hagiwara, H.;
    • Oshita, M.;
    • Mita, E.;
    • Fukui, H.;
    • Inada, M.;
    • Tamura, S.;
    • Yoshihara, H.;
    • Hayashi, E.;
    • Inoue, A.;
    • Imai, Y.;
    • Kato, M.;
    • Miyagi, T.;
    • Hohsui, A.;
    • Ishida, H.;
    • Kiso, S.
    Publication type:
    Article
    39
    40
    41
    42
    43

    Editorial.

    Published in:
    2010
    By:
    • Strickland, G. T.
    Publication type:
    Editorial
    44
    45
    46
    47
    48
    49
    50